Plasminogen is an important regulator in the pathogenesis of a murine model of asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 176, Issue 4, 2007, Pages 333-342

  Swaisgood, Carmen M ^a   Aronica, Mark A ^a   Swaidani, Shadi ^a   Plow, Edward F ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Fibrinolysis; Knockout mice; Lung; Pulmonary inflammation

Indexed keywords

COLLAGEN; CYTOKINE; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE; GELATINASE A; GELATINASE B; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; OVALBUMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR; RANTES; TRANEXAMIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BAGG ALBINO MOUSE; BRONCHUS MUCUS; C57BL 6 MOUSE; CELL MIGRATION; CONTROLLED STUDY; EOSINOPHIL COUNT; HISTOPATHOLOGY; IMMUNE RESPONSE; INFLAMMATION; KNOCKOUT MOUSE; LEUKOCYTOSIS; LUNG LAVAGE; LYMPHOCYTE COUNT; MORPHOMETRICS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; ANTIFIBRINOLYTIC AGENTS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; COLLAGEN; DISEASE MODELS, ANIMAL; EOSINOPHILS; GELATINASES; INFLAMMATION; INTERLEUKIN-5; LEUKOCYTOSIS; LUNG; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MUCUS; PLASMINOGEN; TRANEXAMIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34547928163     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200609-1345OC     Document Type: Article

References (62)

1. Djukanovic R, Holgate ST. An atlas of asthma. New York: Parthenon Publishing; 1999.
2. Li X, Wilson JW. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 1997;156:229-233.
3. Barbato A, Turato G, Baraldo S, Bazzan E, Calabrese F, Tura M, Zuin R, Beghe B, Maestrelli P, Fabbri LM, et al. Airway inflammation in childhood asthma. Am J Respir Crit Care Med 2003;168:798-803.
4. Castellino FJ, Ploplis VA. Structure and function of the plasminogen/ plasmin system. Thromb Haemost 2005;93:647-654.
5. Bonnefoy A, Legrand C. Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase. Thromb Res 2000;98:323-332.
6. Liotta LA, Goldfarb RH, Brundage GP, Siegal GP, Terranova V, Garbisa S. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 1981;41:4629-4636.
7. Lijnen HR. Molecular interactions between the plasminogen/plasmin and matrix metalloproteinase systems. Fibrinolysis Proteolysis 2000;14:175-181.
8. Ploplis VA, French EL, Carmeliet P, Collen D, Plow EF. Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. Blood 1998;91:2005-2009.
9. Plow EF, Ploplis VA, Carmeliet P, Collen D. Plasminogen and cell migration in vivo. Fibrinolysis Proteolysis 1999;13:49-53.
10. Swaisgood CM, French EL, Noga C, Simon RH, Ploplis VA. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system. Am J Pathol 2000;157:177-187.
11. Banach-Wawrzenczyk E, Dziedziczko A, Rosc D. Fibrinolysis system in patients with bronchial asthma. Med Sci Monit 2000;6:103-107.
12. Ferland C, Guilbert M, Davoine F, Flamand N, Chakir J, Laviolette M. Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system. J Leukoc Biol 2001;69:772-778.
13. Lloyd CM, Gutierrez-Ramos JC. Animal models to study chemokine receptor function: in vivo mouse models of allergic airway inflammation. Methods Mol Biol 2004;239:199-210.
14. Swaisgood CM, Swaidani S, Erzurum S, Aronica MA, Plow EF. Plasminogen regulation of pathogenesis of asthma [abstract]. Am J Respir Crit Care Med 2004;169:A81.
15. Ploplis VA, Carmeliet P, Vazirzadeh S, Van Vlaenderen I, Moons L, Plow EF, Collen D. Effects of disruption of the plasminogen gene in mice on thrombosis, growth and health. Circulation 1995;92:2585-2593.
16. Gonzalo J-A, Lloyd CM, Kremer L, Finger E, Martinez-A. C, Siegelman MH, Cybulsky M, Gutierrez-Ramos J-C. Eosinophil recruitment to the lung in amurine model of allergic inflammation: the role of T cells, chemokines, and adhesion receptors. J Clin Invest 1996;98:2332-2345.
17. Aronica MA, McCarthy S, Swaidani S, Mitchell D, Goral M, Sheller JR, Boothby M. Recall helper T cell response: T helper 1 cell-resistant allergic susceptibility without biasing uncommitted CD4 T cells. Am J Respir Crit Care Med 2004;169:587-595.
18. Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE, Ghiran S, Gerard NP, Yu C, Orkin SH, et al. A critical role for eosinophils in allergic airways remodeling. Science 2004;305:1776-1779.
19. Reinhardt AK, Bottoms SE, Laurent GJ, McAnulty RJ. Quantification of collagen and proteoglycan deposition in a murine model of airway remodelling. Respir Res 2005;6:30.
20. Tanaka H, Masuda T, Tokuoka S, Takahashi Y, Komai M, Nagao K, Nagai H. Time course study on the development of allergen-induced airway remodeling in mice: the effect of allergen avoidance on established airway remodeling. Inflamm Res 2002;51:307-316.
21. Busuttil SJ, Ploplis VA, Castellino FJ, Tang L, Eaton JW, Plow EF. A central role for plasminogen in the inflammatory response to biomaterials. J Thromb Haemost 2004;2:1798-1805.
22. Cataldo DD, Tournoy KG, Vermaelen K, Munaut C, Foidart JM, Louis R, Noel A, Pauwels RA. Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. Am J Pathol 2002;161:491-498.
23. Vermaelen KY, Cataldo D, Tournoy K, Maes T, Dhulst A, Louis R, Foidart JM, Noel A, Pauwels R. Matrix metalloproteinase-9-mediated dendritic cell recruitment into the airways is a critical step in a mouse model of asthma. J Immunol 2003;171:1016-1022.
24. Renauld JC. New insights into the role of cytokines in asthma. J Clin Pathol 2001;54:577-589.
25. Lyons RM, Keski-Oja J, Moses HL. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol 1988;106:1659-1665.
26. Taipale J, Koli K, Keski-Oja J. Release of transforming growth factorbeta 1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. J Biol Chem 1992;267:25378-25384.
27. Kumar RK, Herbert C, Foster PS. Expression of growth factors by airway epithelial cells in a model of chronic asthma: regulation and relationship to subepithelial fibrosis. Clin Exp Allergy 2004;34:567-575.
28. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-1039.
29. Ploplis VA, Castellino FJ. Nonfibrinolytic functions of plasminogen. Methods 2000;21:103-110.
30. Swaisgood CM, Schmitt D, Eaton D, Plow EF. In vivo regulation of plasminogen function by plasma carboxypeptidase B. J Clin Invest 2002;110:1275-1282.
31. O'Bourne PM. Allergen-induced airway hyperresponsiveness. J Allergy Clin Immunol 1988;81:119-127.
32. Lee SA, Fitzgerald SM, Huang SK, Li C, Chi DS, Milhorn DM, Krishnaswamy G. Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1β. Am J Respir Cell Mol Biol 2004;31:283-291.
33. Pabst R, Tschernig T. Perivascular capillaries in the lung: an important but neglected vascular bed in immune reactions? J Allergy Clin Immunol 2002;110:209-214.
34. Nykjaer A, Moller B, Todd RF III, Christensen T, Andreasen PA, Gliemann J, Petersen CM. Urokinase receptor: an activation antigen in human T lymphocytes. J Immunol 1994;152:505-516.
35. Dahl R, Venge P. Enhancement of urokinase-induced plasminogen activation by the cationic protein of human eosinophil granulocytes. Thromb Res 1979;14:599-608.
36. Schweizer RC, Kessel-Welmers BA, Warringa RA, Maikoe T, Raaijmakers JA, Lammers JW, Koenderman L. Mechanisms involved in eosinophil migration: platelet-activating factor-induced chemotaxis and interleukin-5-induced chemokinesis are mediated by different signals. J Leukoc Biol 1996;59:347-356.
37. Guilbert M, Ferland C, Bosse M, Flamand N, Lavigne S, Laviolette M. 5-Oxo-6,8,11,14-eicosatetraenoic acid induces important eosinophil transmigration through basement membrane components: comparison of normal and asthmatic eosinophils. Am J Respir Cell Mol Biol 1999;21:97-104.
38. Brooks AM, Bates ME, Vrtis RF, Jarjour NN, Bertics PJ, Sedgwick JB. Urokinase-type plasminogen activator modulates airway eosinophil adhesion in asthma. Am J Respir Cell Mol Biol 2006;35:503-511.
39. Begin P, Tremblay K, Daley D, Lemire M, Claveau S, Salesse C, Kacel S, Montpetit A, Becker A, Chan-Yeung M, et al. Association of urokinase-type plasminogen activator with asthma and atopy. Am J Respir Crit Care Med 2007;175:1109-1116.
40. Gabbrielli S, Di Lollo S, Stanflin N, Romagnoli P. Myofibroblast and elastic and collagen fiber hyperplasia in the bronchial mucosa: a possible basis for the progressive irreversibility of airway obstruction in chronic asthma. Pathologica 1994;86:157-160.
41. Cho SH, Seo JY, Choi DC, Yoon HJ, Cho YJ, Min KU, Lee GK, Seo JW, Kim YY. Pathological changes according to the severity of asthma. Clin Exp Allergy 1996;26:1210-1219.
42. Benayoun L, Druilhe A, Dombret MC, Aubier M, Pretolani M. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 2003;167:1360-1368.
43. Minshall EM, Leung DY, Martin RJ, Song YL, Cameron L, Ernst P, Hamid Q. Eosinophil-associated TGF-1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1997;17:326-333.
44. Tanaka H, Masuda T, Tokuoka S, Komai M, Nagao K, Takahashi Y, Nagai H. The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma. Inflamm Res 2001;50:616-624.
45. Oh CK, Ariue B, Alban RF, Shaw B, Cho SH. PAI-1 promotes extracellular matrix deposition in the airways of a murine asthma model. Biochem Biophys Res Commun 2002;294:1155-1160.
46. Kumagai K, Ohno I, Okada S, Ohkawara Y, Suzuki K, Shinya T, Nagase H, Iwata K, Shirato K. Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J Immunol 1999;162:4212-4219.
47. Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 2003;28:12-24.
48. Ohno I, Ohtani H, Nitta Y, Suzuki J, Hoshi H, Honma M, Isoyama S, Tanno Y, Tamura G, Yamauchi K, et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1997;16:212-219.
49. Han Z, Junxu, Zhong N. Expression of matrix metalloproteinases MMP-9 within the airways in asthma. Respir Med 2003;97:563-567.
50. Hoshino M, Nakamura Y, Sim J, Shimojo J, Isogai S. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol 1998;102:783-788.
51. Wenzel SE, Balzar S, Cundall M, Chu HW. Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair. J Allergy Clin Immunol 2003;111:1345-1352.
52. McMillan SJ, Kearley J, Campbell JD, Zhu XW, Larbi KY, Shipley JM, Senior RM, Nourshargh S, Lloyd CM. Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. J Immunol 2004;172:2586-2594.
53. Cataldo D, Munaut C, Noel A, Frankenne F, Bartsch P, Foidart JM, Louis R. MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 2000;123:259-267.
54. Maisi P, Prikk K, Sepper R, Pirila E, Salo T, Hietanen J, Sorsa T. Soluble membrane-type 1 matrix metalloproteinase (MT1-MMP) and gelatinase A (MMP-2) in induced sputum and bronchoalveolar lavage fluid of human bronchial asthma and bronchiectasis. APMIS 2002;110:771-782.
55. Fowlkes JL, Winkler MK. Exploring the interface between metalloproteinase activity and growth factor and cytokine bioavailability. Cytokine Growth Factor Rev 2002;13:277-287.
56. Winkler MK, Fowlkes JL. Metalloproteinase and growth factor interactions: do they play a role in pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol 2002;283:L1-11.
57. Das AM, Ajuebor MN, Flower RJ, Perretti M, McColl SR. Contrasting roles for RANTES and macrophage inflammatory protein-1 alpha (MIP-1 alpha) in a murine model of allergic peritonitis. Clin Exp Immunol 1999;117:223-229.
58. Robinson SC, Scott KA, Balkwill FR. Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha. Eur J Immunol 2002;32:404-412.
59. Schwingshackl A, Duszyk M, Brown N, Moqbel R. Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha. J Allergy Clin Immunol 1999;104:983-989.
60. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996;183:195-201.
61. Elias JA, Lee CG, Zheng T, Ma B, Homer RJ, Zhu Z. New insights into the pathogenesis of asthma. J Clin Invest 2003;111:291-297.
62. Gonzalo JA, Lloyd CM, Wen D, Albar JP, Wells TN, Proudfoot A, Martinez A, Dorf M, Bjerke T, Coyle AJ, et al. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med 1998;188:157-167.